Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Tasly Pharmaceutical
AddedFeb 15, 2024
UpdatedJun 28, 2026
Tasly Pharmaceutical

Tasly Pharmaceutical

Public

Tasly pioneers modern Traditional Chinese Medicine, proving natural herbs can effectively treat serious diseases.

HQ
Tianjin, Guangdong, CN
Founded
1994
Overview
Compare
Employees

Tasly Pharmaceutical pioneers modern Traditional Chinese Medicine (mTCM), scientifically proving that natural herbs can effectively treat serious diseases. They aim to fulfill unmet clinical needs by offering chemical-free products, providing an alternative to synthetic drug compounds.

Tasly has made significant strides in integrating mTCM into modern healthcare, impacting patient treatment options worldwide. Their innovative approach has garnered attention and support from both healthcare providers and patients, positioning them as a leader in natural medicine.

Tasly Pharmaceutical - Similar Companies

Telsar Pharma logo

Telsar Pharma

Taiho Pharmaceutical Co. logo

Taiho Pharmaceutical Co.

taiho.co.jp

WeFine Health Technology logo

WeFine Health Technology

wefinehealth.com

Yantai Dongcheng Pharmaceutical Co logo

Yantai Dongcheng Pharmaceutical Co

dcb-group.com

Tarsus Pharmaceuticals logo

Tarsus Pharmaceuticals

tarsusrx.com

Betta Pharmaceuticals Co. logo

Betta Pharmaceuticals Co.

bettapharma.com

Taisho Pharmaceutical Holdings Co. logo

Taisho Pharmaceutical Holdings Co.

Tigermed logo

Tigermed

Ziran Biopharmaceutical logo

Ziran Biopharmaceutical

Haisco logo

Haisco

Sino Biopharmaceutical logo

Sino Biopharmaceutical

Shenzhen Salubris Pharmaceuticals Co. logo

Shenzhen Salubris Pharmaceuticals Co.

China Grand Pharmaceutical and Healthcare Holdings logo

China Grand Pharmaceutical and Healthcare Holdings

Taiwan Biotech Co. logo

Taiwan Biotech Co.

sintong.com

Moksha8 logo

Moksha8

moksha8.com

Tasly Pharmaceutical - Quick Facts

Who are Tasly Pharmaceutical's competitors?

Companies similar to Tasly Pharmaceutical include Telsar Pharma, Taiho Pharmaceutical Co., WeFine Health Technology and Yantai Dongcheng Pharmaceutical Co.

When was Tasly Pharmaceutical founded?

Tasly Pharmaceutical was founded in 1994.

Where is Tasly Pharmaceutical's headquarters located?

Tasly Pharmaceutical's headquarters is located in Tianjin, Guangdong, CN.

How many employees does Tasly Pharmaceutical have?

Tasly Pharmaceutical has 1 employee as of Feb 1, 2024.

Tasly Pharmaceutical - Classification

Industry
  • Retail
Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Transactional
Customer
  • Consumers
Main Product
  • Herbal Medicine
  • Pharmaceuticals
Tags
  • Distribution
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations